Nina E de Groot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nina E de Groot has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Clara C Elbers
Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine Amsterdam UMC Location University of Amsterdam Amsterdam The Netherlands
1 shared publication - Jarom Heijmans
Affiliations Amsterdam UMC, University of Amsterdam, department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands, Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands, Amsterdam Gastroenterology Endocrinology and Metabolism institute, Amsterdam, The Netherlands
1 shared publication - Lisanne E. Nijman
Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands
1 shared publication - Louis Vermeulen
Laboratory of Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Amsterdam UMC and University of Amsterdam, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands
1 shared publication - Milou S. van Driel
Amsterdam UMC, location University of Amsterdam, Laboratory for Experimental Oncology and Radiobiology, van der Boechorststraat 6b, 1081BT, Amsterdam, The Netherlands
1 shared publication - Nicolas Léveillé
Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 2 November 2022
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 14 (12) , e16194
Intestinal Apc‐inactivation induces HSP25 dependency
The majority of colorectal cancers (CRCs) present with early mutations in tumor suppressor gene APC. APC mutations result in oncogenic activation of the Wnt pathway, which is associated with hyperproliferation, cytoskeletal remodeling, and a global increase in mRNA translation. To compensate for the increased biosynthetic demand, cancer cells critically depend on protein chaperones to maintain proteostasis, although their function in CRC remains largely unexplored. In order to investigate the role of molecular chaperones in driving CRC initiation, we captured the transcriptomic profiles of murine wild type and Apc‐mutant organoids during active transformation. We discovered a strong transcriptional upregulation of Hspb1, which encodes small heat shock protein 25 (HSP25). We reveal an indispensable role for HSP25 in facilitating Apc‐driven transformation, using both in vitro organoid cultures and mouse models, and demonstrate that chemical inhibition of HSP25 using brivudine reduces the development of premalignant adenomas. These findings uncover a hitherto unknown vulnerability in intestinal transformation that could be exploited for the development of chemopreventive strategies in high‐risk individuals.
- 2 November 2022
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 14 (12) , e16194
Open AccessIntestinal Apc‐inactivation induces HSP25 dependency
The majority of colorectal cancers (CRCs) present with early mutations in tumor suppressor gene APC. APC mutations result in oncogenic activation of the Wnt pathway, which is associated with hyperproliferation, cytoskeletal remodeling, and a global increase in mRNA translation. To compensate for the increased biosynthetic demand, cancer cells critically depend on protein chaperones to maintain proteostasis, although their function in CRC remains largely unexplored. In order to investigate the role of molecular chaperones in driving CRC initiation, we captured the transcriptomic profiles of murine wild type and Apc‐mutant organoids during active transformation. We discovered a strong transcriptional upregulation of Hspb1, which encodes small heat shock protein 25 (HSP25). We reveal an indispensable role for HSP25 in facilitating Apc‐driven transformation, using both in vitro organoid cultures and mouse models, and demonstrate that chemical inhibition of HSP25 using brivudine reduces the development of premalignant adenomas. These findings uncover a hitherto unknown vulnerability in intestinal transformation that could be exploited for the development of chemopreventive strategies in high‐risk individuals.